Ethical Compliance
LUPIN
Sector:
Healthcare
Industry:
Drug Manufacturers - Specialty & Generic
Market Cap Class:
large
Revenue
0.4%
Debt
11.1%
Liquidity
5%
Revenue
Debt
Liquidity
0.4%
Non Compliant
Questionable
Compliant
Compliant
INR Crores
| Sale of Pharmaceuticals Products | ₹19,945.20 |
| Other Income | ₹49.45 |
| Research & other | ₹67.14 |
Questionable
INR Crores
Non Compliant
INR Crores
| interest & other | ₹70.72 |
INR Crores
| Revenue from Questionable Sources: | ₹0.00 |
| Revenue from Non Compliant Sources: | ₹70.72 |
| Total: | ₹70.72 |
| Total Revenue: | ₹20,132.51 |
Formula
Revenue from Questionable & Non Compliant Sources
Total Revenue
≤ 0.03 or 3%
Calculation
₹70.72
₹20,132.51
= 0.4%
compliant
Rationale
The sum of revenue from questionable and non-compliant sources should not exceed 3% of the total revenue. This ensures that the company has tolerable reliance on unethical sources of revenue.
